3 ms·
So I’m not a biochemist or an MD or similar but this seems to say that they think they found which pre existing human antibody targets a particular covid 19 pro
by LatteLazy 7y ago
So I’m not a biochemist or an MD or similar but this seems to say that they think they found which pre existing human antibody targets a particular covid 19 protein. And since that antibody (like all antibodies) is really hard to manufacture, someone now needs to develop a drug with a similar enough shape to do the same job (while also being non toxic and stable in the body).
We’re already harvesting antibodies from people who produce them (people who had covid and recovered) and using them to treat (or prevent) covid in others. But that’s expensive so it’s strictly for those who can pay...
- vikramkr 7y agoNot exactly, but on the right line of thought. Antibody drugs are a common type of drug (think humira) thatbaremt that hard to manufacture (compared to something like a gene therapy). And their platform is an antibody design platform, so they've used it to design and screen antibodies to find one that will bind to and neutralize the covid virus. They're not the only ones either, there have been a few discovered so far. The next steps are to move them into clinical trials just producing these antibodies as the drug, no need for finding anything with a similar shape
- gedy 7y ago> is expected to be able to produce up to two hundred thousand doses per month and the Company intends to produce a million doses at risk while seeking FDA approval "Is expected" might be the caveat, but does sound promising from a scale perspective.
- LatteLazy 7y agoYeah, I wondered about that: is one dose enough for complete treatment 1 person or is it one "pill" and patients need X pills per day for Y days?